[go: up one dir, main page]

WO2014182691A2 - Fil a mémoire de forme en alliage titane-niobium-hafnium - Google Patents

Fil a mémoire de forme en alliage titane-niobium-hafnium Download PDF

Info

Publication number
WO2014182691A2
WO2014182691A2 PCT/US2014/036961 US2014036961W WO2014182691A2 WO 2014182691 A2 WO2014182691 A2 WO 2014182691A2 US 2014036961 W US2014036961 W US 2014036961W WO 2014182691 A2 WO2014182691 A2 WO 2014182691A2
Authority
WO
WIPO (PCT)
Prior art keywords
wire
shape
memory
alloy
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2014/036961
Other languages
English (en)
Other versions
WO2014182691A3 (fr
Inventor
Jeremy E. Schaffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fort Wayne Metals Research Products LLC
Original Assignee
Fort Wayne Metals Research Products LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fort Wayne Metals Research Products LLC filed Critical Fort Wayne Metals Research Products LLC
Priority to US14/889,101 priority Critical patent/US10315012B2/en
Publication of WO2014182691A2 publication Critical patent/WO2014182691A2/fr
Publication of WO2014182691A3 publication Critical patent/WO2014182691A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09—Guide wires
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C14/00—Alloys based on titanium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • A61L31/022—Metals or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21D—MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING
    • C21D1/00—General methods or devices for heat treatment, e.g. annealing, hardening, quenching or tempering
    • C21D1/26—Methods of annealing
    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21D—MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING
    • C21D8/00—Modifying the physical properties by deformation combined with, or followed by, heat treatment
    • C21D8/06—Modifying the physical properties by deformation combined with, or followed by, heat treatment during manufacturing of rods or wires
    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21D—MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING
    • C21D9/00—Heat treatment, e.g. annealing, hardening, quenching or tempering, adapted for particular articles; Furnaces therefor
    • C21D9/52—Heat treatment, e.g. annealing, hardening, quenching or tempering, adapted for particular articles; Furnaces therefor for wires; for strips ; for rods of unlimited length
    • C21D9/525—Heat treatment, e.g. annealing, hardening, quenching or tempering, adapted for particular articles; Furnaces therefor for wires; for strips ; for rods of unlimited length for wire, for rods
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C30/00—Alloys containing less than 50% by weight of each constituent
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
    • C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
    • C22F1/006—Resulting in heat recoverable alloys with a memory effect
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
    • C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
    • C22F1/16—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of other metals or alloys based thereon
    • C22F1/18—High-melting or refractory metals or alloys based thereon
    • C22F1/183—High-melting or refractory metals or alloys based thereon of titanium or alloys based thereon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/16—Materials with shape-memory or superelastic properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09—Guide wires
    • A61M2025/09133—Guide wires having specific material compositions or coatings; Materials with specific mechanical behaviours, e.g. stiffness, strength to transmit torque
    • A61M2025/09141—Guide wires having specific material compositions or coatings; Materials with specific mechanical behaviours, e.g. stiffness, strength to transmit torque made of shape memory alloys which take a particular shape at a certain temperature
    • C—CHEMISTRY; METALLURGY
    • C21—METALLURGY OF IRON
    • C21D—MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING
    • C21D2201/00—Treatment for obtaining particular effects
    • C21D2201/01—Shape memory effect

Definitions

  • the present disclosure relates to shape-memory alloy wire and, in particular, relates to a method of manufacturing wire made of a shape memory alloy which demonstrates wire properties appropriate for in vivo use, as well as medical devices made with such wire.
  • Shape memory materials are materials that "remember" their original shape, and which, after being deformed, return to that shape either spontaneously or by applying heat to raise their temperature above a processing and material related threshold known as the transformation temperature. Materials which are heated to recover shape are commonly referred to in the art as “shape memory” materials, whereas materials which spontaneously recover to a particular shape upon removal of a constraining force are commonly referred to as pseudoelastic materials. Shape memory materials, possessing relatively high transformation temperatures, are commonly used in thermally activated actuation devices, for example in military, automotive or robotic devices whereas pseudoelastic materials are commonly used in highly flexible implantable medical devices.
  • Fig. 1 schematically illustrates superelastic behavior in the context of a stress-strain curve for a superelastic material.
  • a superelastic stress-strain curve exhibits a nonlinear correlation between load (i.e., stress) and displacement (i.e., strain).
  • load i.e., stress
  • displacement i.e., strain
  • Superelastic behavior is exhibited by the shape of the stress-strain curve across ⁇ 2 , which disrupts the end of this linear elastic correlation with a substantial increase in strain with little or no increase in stress.
  • the magnitude of ⁇ 2 can be considered to be the "amount" or level of loading superelasticity exhibited by a material.
  • phase transformation occurs between austenite and martensite.
  • the material may experience a further linear elastic deformation through ⁇ 3 .
  • linear elastic behavior is again exhibited for the initial unloading process, with superelastic behavior occurring across ⁇ 4 .
  • the magnitude of ⁇ 4 can be considered to be the "amount” or level of unloading superelasticity exhibited by a material.
  • the unloading superelasticity quantified by ⁇ 4 is smaller, and occurs and a lower stress, as compared to the loading superelasticity quantified by ⁇ 2 . This disparity between loading and unloading behavior is a feature of superelastic materials.
  • a pseudoelastic material may return to its previous shape after the removal of even relatively high applied strains by heating. For example, even if the secondary or daughter domain boundaries do become pinned, for example due to dislocations associated with plasticity, the material may be reverted to the primary or parent phase by stresses generated through heating.
  • Pseudoelasticity is generally exhibited in shape memory alloys. Pseudoelasticity and shape memory both arise from the reversible motion of domain boundaries during the phase transformation, rather than just bond stretching or the introduction of defects in the crystal lattice.
  • shape memory materials include iron-chrome -nickel, iron-manganese, iron- palladium, iron-platinum, iron-nickel-cobalt-titanium, iron-nickel-cobalt-tantalum-aluminum- boron, copper-zinc-aluminum, copper-zinc-aluminum-nickel, copper-aluminum-nickel, and nickel-titanium alloys. Shape memory materials can also be alloyed with other materials including zinc, copper, gold, and iron.
  • Shape memory materials are presently used in a variety of applications. For example, a variety of military, medical, safety and robotic applications for shape memory materials are known. Medical grade shape memory materials are used for orthodontic wires, guide wires to guide catheters through blood vessels, surgical anchoring devices and stent applications, for example.
  • NiTi biocompatible implant grade materials
  • nickel-titanium material nickel-titanium shape memory material
  • Nitinol an approximately equiatomic nickel-titanium, binary shape memory material
  • alloys including nickel and titanium as primary constituents but which also include one or more additional elements as secondary constituents, such as Nitinol tertiary or quaternary alloys (e.g., Nitinol with additive metals such as chromium, tantalum, palladium, platinum, iron, cobalt, tungsten, iridium and gold).
  • Wire products made of shape memory materials are manufactured by forming a relatively thick piece of hot- worked rod stock from a melt process. The rod stock is then further processed into wires by drawing the rod stock down to a thin diameter wire.
  • a drawing process often referred to as a "cold working” process, a wire is pulled through a lubricated die to reduce its diameter.
  • the deformation associated with wire drawing increases the stress in the material, and the stress eventually must be relieved by various methods of heat treatment or annealing at elevated temperatures to restore ductility, thus enabling the material to undergo further cold working to further reduce the wire diameter.
  • pseudoelastic wires made in accordance with foregoing processes may demonstrate desirable material properties for in vivo use, such wires are not generally
  • radiopaque i.e., the material of the wire allows X-rays or other types of radiation to pass through and therefore the wire material is not sufficiently distinguishable from surrounding anatomic structures in X-ray images.
  • Substantial design efforts have been focused on imputing radiopacity to in vivo wire materials, such as by creating composite wires which utilize a radiopaque core material surrounded by a biocompatible sleeve suitable for in vivo use. Where in vivo wires are made radiopaque, X-ray imaging equipment can be used to assess, verify and/or monitor the location of the wire within the patient's body.
  • a primary constituent material of NiTi wires is nickel, as noted above. In some instances, it may be desirable to avoid the use of nickel for implanted medical devices, thereby minimizing any chance for adverse in vivo reactions in nickel-sensitive patients.
  • the present disclosure relates to Ti-Nb-Hf/Zr-(Cr) alloy shape-memory wires suitable for use in medical devices and actuators, and methods for manufacturing such wires.
  • the present shape-memory Ti-Nb-Hf/Zr-(Cr) alloy is a superelastic wire material particularly suited for in vivo applications.
  • the present Ti-Nb-Hf/Zr-(Cr) alloy wire is radiopaque, thereby enabling surgical use of a monolithic, shape-memory alloy wire while preserving the ability to monitor the in vivo location of the wire through X-ray or other radiation- based imaging systems.
  • the present Ti-Nb-Hf/Zr-(Cr) alloy can be manufactured to exhibit shape-memory alloy material properties without the use of nickel as an alloy constituent, thereby accommodating nickel-sensitive patients.
  • the present Ti-Nb-Hf/Zr-(Cr) alloy can also be processed to exhibit a martensite/austenite transformation temperature near body-temperature, i.e., 37 °C, so that shape-memory effects can be utilized to accomplish work in vivo.
  • the present invention provides a shape-memory wire for a medical device, the wire including titanium, niobium and at least one of hafnium and zirconium, the wire exhibiting superelastic behavior and having an austenitic finish temperature less than 37 °C.
  • the present invention provides a method for producing a shape-memory wire for a medical device, the method including: imparting between 50% and 99% cold work to a wire including titanium, niobium and at least one of hafnium and zirconium, such that a resulting cold worked wire construct has a final diameter of less than 10 mm; and shape-setting the cold- worked wire construct by annealing the cold worked wire construct at between 400 °C (673 K) and 1000 °C (1273 K) for a period of at less than 120 seconds, the shape-setting step performed while a stress is applied to the wire construct.
  • a method for producing a shape-memory wire for a medical device including: imparting between 50% and 99% cold work to a wire including titanium, niobium and at least one of hafnium and zirconium, such that a resulting cold worked wire construct has a final diameter of less than 10 mm; and shape-setting the cold- worked wire construct by annealing the cold worked wire construct at between
  • Fig. 1 is a schematic stress-strain curve for a superelastic material
  • Fig. 2A is a schematic view of a portion of wire having an equiaxed grain structure
  • FIG. 2B is a schematic view illustrating an exemplary forming process of monolithic wire using a lubricated drawing die
  • FIG. 3 is a schematic view of the portion of wire of Fig. 2 having an elongated grain structure after cold work conditioning in accordance with an embodiment of the present process
  • Fig. 4 is a schematic view of the portion of wire of Fig. 3 having an equiaxed grain structure with smaller grains than the equiaxed grain structure of the wire in Fig. 2A after recrystallization in accordance with an embodiment of the present process;
  • Fig. 5 is a graph illustrating stress vs. strain for a wire made in accordance with the present disclosure, in which the wire was serially subjected to varying, increasing levels of strain at a temperature of 37 °C;
  • Fig. 6 is a graph illustrating stress vs. strain for a wire made in accordance with the present disclosure and a wire made of superelastic NiTi, in which each wire was serially subjected to varying, increasing levels of strain at a temperature of 150 °C;
  • Figs. 7A and 7B are graphs illustrating fatigue life vs. alternating strain level for a wire made in accordance with the present disclosure, a wire made of 316L stainless steel, and a wire made of NiTi;
  • Figs. 7C and 7D are graphs illustrating stress vs. strain for wires made in accordance with the present disclosure
  • Fig. 8 is a partial section view of a guide wire in accordance with an embodiment of the present process
  • Fig. 9 is a partial section view of a heart, illustrating cardiac pacing leads received therein;
  • FIG. 10 is a section, perspective view of a cardiac pacing lead including wire made in accordance with the present process
  • Fig. 11(a) is an elevation view of a braided tissue scaffold or stent including a wire made in accordance with the present process.
  • Fig. 11(b) is an elevation view of a knitted tissue scaffold or stent including a wire made in accordance with the present process.
  • the present disclosure relates to shape memory wire products, and medical devices including shape memory wire products, such as round and flat wire, strands, cables, coils, and tubing, made from a shape memory material or alloy.
  • shape memory wire products such as round and flat wire, strands, cables, coils, and tubing, made from a shape memory material or alloy.
  • These wire products are formed from a titanium-niobium-hafnium/zirconium metal alloy, and may further include other alloying elements such as chromium.
  • the material may be referred to herein as Ti-Nb-Hf, Ti-Nb- Zr, Ti-Nb-Hf/Zr, or Ti-Nb-Hf/Zr-(Cr) (where chromium is in parens to indicate its optional status of a constituent of the alloy).
  • the wire is processed to produce products exhibiting a low modulus of elasticity, superelastic behavior, and shape memory behavior in body-temperature environments.
  • titanium-niobium-hafnium/zirconium Ti-Nb-
  • Hf/Zr alloys made in accordance with the present disclosure include titanium present at 30-70 wt.%, niobium present at 15-35 wt.%, and hafnium and/or zirconium present at 11-31 wt.%.
  • Hafnium and Zirconium are considered to be interchangeable in the present alloy, in that one can be substituted for the other in any amount up to the total constituency of Hf/Zr.
  • the alloy may include 21 wt.% hafnium, 21 wt.% zirconium, or any combination of hafnium and zirconium totaling 21 wt.% (e.g., 1 wt.% Hf and 20 wt.% Zr, 11 wt.% Hf and 10 wt.% Zr, etc.).
  • zirconium is similar to hafnium and is present in commercially pure hafnium.
  • a wire made in accordance with the present disclosure may exclude zirconium, it is also contemplated that zirconium may replace any portion of the hafnium constituent of the wire while maintaining a material system suitable for use in medical or actuator devices as described below.
  • the amount of titanium in the present Ti-Nb-Hf/Zr alloy may be as little as 30 wt.%), 40 wt.%), or 50 wt.% and as much as 56 wt.%, 60 wt.%, or 70 wt.%, or may be any value within any range defined by any of the foregoing values.
  • the amount of niobium in the present Ti-Nb-Hf/Zr alloy may be as little as 15 wt.%, 20 wt.%, or 22 wt.% and as much as 28 wt.%, 30 wt.%), or 35 wt.%), or may be any value within any range defined by any of the foregoing values.
  • the amount of hafnium and/or zirconium in the present Ti-Nb-Hf/Zr alloy may be as little as 11 wt.%), 16 wt.%), or 18 wt.% and as much as 24 wt.%, 26 wt.%, or 31 wt.%, or may be any value within any range defined by any of the foregoing values.
  • wire in accordance with the present disclosure is made from a ternary Ti-25Nb-21Hf alloy (i.e., 25 wt.% niobium, 21 wt.% hafnium, and balance titanium at 54 wt.%).
  • wire in accordance with the present disclosure is made from a quaternary Ti-24.8Nb-16.2Hf-lZr alloy (i.e., 24.8 wt.% niobium, 16.2 wt.% hafnium, 1 wt.% zirconium and balance titanium at 58 wt.%).
  • Chromium may optionally be alloyed with wire in accordance with the present disclosure.
  • the amount of chromium in a Ti-Nb-Hf/Zr-Cr alloy may be as little as 0.05 wt.%, 0.2 wt.%), or 0.4 wt.%) and as much as 0.6 wt.%, 0.8 wt.%, or 1 wt.%, or may be any value within any range defined by any of the foregoing values.
  • the present alloy may exhibit austenite and martensite phases based on temperature.
  • austenite phase upon cooling the material begins to transform to martensite at the martensite start (Ms) temperature with complete transformation to martensite occurring by the martensite finish (Mp) temperature.
  • Ms martensite start
  • Mp martensite finish
  • the material Upon heating from the martensite phase, the material begins to transform to austenite at the austenite start (As) temperature with complete transformation to austenite occurring at the austenite finish (Ap) temperature.
  • a F ingot or active austenitic finish temperatures
  • shape memory wire made in accordance with the present disclosure may be used in medical devices such as, for example, implantable cardiac pacing, shocking and/or sensing leads, implantable neurological stimulating and/or sensing leads, wire-based stents, medial guidewires, catheters, blood filter devices, or any other medical device application in which a shape memory or superelastic characteristic is desired.
  • Wire products produced in accordance with the present disclosure may also be used in non-medical device applications in which a shape memory or superelastic characteristic is desired, for example in shape memory actuator applications which utilize the shape
  • wire or “wire product” encompasses continuous wire and wire products which may be continuously produced and wound onto a spool for later dispensation and use, such as wire having a round cross section and wire having a non-round cross section, including flat wire or ribbon.
  • Wire or “wire product” also encompasses other wire-based products such as strands, cables, coil, and tubing, which may be produced at a particular length depending on a particular application.
  • the principles of the present disclosure can be used to manufacture other material forms such as rod materials having a diameter of less than 5 mm and thin material sheets.
  • This exemplary process includes first procuring a "coarse" wire material that is fully annealed. This coarse wire material forms the starting point for processing in accordance with the present disclosure, and may be produced from an ingot by an iterative drawing/annealing process as described below.
  • the coarse wire is then drawn to a fine wire diameter of 10 mm or less without intervening annealing. This drawing process introduces a large amount of cold work and associated internal stresses within the wire material, which are not "reset" by a full annealing process.
  • the cold-worked wire is subjected to a shape setting process in which the wire is formed into a desired shape or otherwise placed under load, then partially annealed to only slightly relieve the cold work and internal stresses.
  • the resulting wire exhibits superelastic behavior in a nickel-free and radiopaque construct which exhibits shape-memory transition behavior at body temperature.
  • Initial preparation of a wire may involve first forming a piece of rod stock, for example, based on conventional melt processing techniques, followed by one or more iterations of warm or hot working, such as by forging or extrusion, and conventional iterative cold working and annealing.
  • an ingot may be melted using an arc-melting, cold crucible technique in order to cast rods having a diameter larger than the coarse wire.
  • These rods can then be hot extruded, such as at about 900 °C, in order to effect a large area reduction (e.g., 8: 1) to create intermediate rod stock.
  • Full annealing may optionally be performed after hot working to achieve equiaxed microstructure.
  • These extruded rods are then drawn by cold-drawing techniques described herein to create the coarse wire structure.
  • the cold work process imparts cold work which is stored in the material microstructure, as further described herein.
  • the iterative drawing/annealing process to reduce the diameter of the rod stock from its as-formed diameter to an initial wire diameter is accomplished by fully annealing the material between draws.
  • full annealing the cold-worked material is heated to a temperature sufficient to substantially fully relieve the internal stresses stored in the material and regrow the material grains to their pre-processing mean grain size, thereby relieving the stored cold work and "resetting" cold work to zero.
  • full annealing is accomplished at a temperature about 700 °C for at least 30 minutes.
  • a full anneal can be accomplished with a higher temperature, such as between 900 °C and 1200 °C, for a shorter time, such as between 10 seconds and 10 minutes.
  • a relatively higher temperature annealing process can utilize a relatively shorter time to achieve a full anneal, while a relatively lower temperature will typically utilize a relatively longer time to achieve a full anneal.
  • Whether a full anneal has been accomplished can be verified in a number of ways as well known in the art, such as microstructural examinations using scanning electron microscopy (SEM), mechanical testing for ductility, strength, elasticity, etc., and other methods.
  • SEM scanning electron microscopy
  • FIG. 2A a schematic or exaggerated view of a portion of wire 10 manufactured in accordance with conventional cold working and annealing techniques is shown. Wire 10 has been subjected to one or more, perhaps several or a very large number of, iterations of conventional cold working and annealing, as described above, to form an equiaxed crystal structure within the material of wire 10.
  • Fig. 2A illustrates representative full-size, equiaxed crystals 12 in the material of pre-processing wire 10.
  • equiaxed refers to a crystal structure in which the individual crystals 12 have axes that are approximately the same length, such that the crystals 12 collectively have a large number of slip planes, leading to high strength and ductility.
  • ductility is defined as the strain capacity of a material to rupture, as measured by a monotonic tensile test with a gauge length exceeding 250x the diameter or thickness of the wire at a temperature of 298 ⁇ 5K.
  • Material strength includes yield ultimate tensile strength (i.e., the level of stress the material will bear prior to rupture) and yield strength (i.e., the level of stress the material will bear prior to a specified amount of plastic deformation).
  • the grain structure may, for example, contain deformed grains that have been recovered to the parent phase through a high temperature anneal process described herein.
  • the resulting coarse wire is ready for further processing to create a wire product which exhibits superelastic and/or shape memory behavior as described in detail below.
  • the exemplary embodiment shown and described herein is focused on a wire construct, it is contemplated that the process may also be employed to create other constructs using the same principles.
  • Alternative constructs include strips of flat material and hollow tube materials.
  • a round wire is shown in the drawings of Figs. 2A, 2B, 3 and 4, other cross-sectional wire geometries may be created (e.g., square, rectangular, or other polygonal).
  • cold work conditioning means imparting a relatively large amount of cold work to a material, such as by wire drawing, swaging, or otherwise forming.
  • the cold work conditioning step is performed by drawing wire 10 through lubricated dies 22,24 (Fig. 2B) defining an output diameter D 2 , which is less than the initial diameter Di of the undrawn wire 10 shown in Fig. 3.
  • the cold work conditioning step by which the diameter of wire 10 is reduced from Di to D 2 is performed in a single draw and, in another embodiment, the cold work conditioning step by which the diameter of wire 10 is reduced from Di to D 2 is performed in multiple draws which are performed sequentially without any annealing step therebetween.
  • the lack of an intervening annealing step causes cold work to "accumulate" in the wire material, rather than being reset to zero as is done with the iterative draw/anneal preprocessing as described above.
  • Such "accumulated" cold work, whether imparted by a single drawing step or multiple draws, is calculated by the following formula, where D 2 is the wire diameter after the cold- work draw or draws is complete and Di is the wire diameter before the cold-work draw or draws have begun:
  • cold work between 90% and 99% is used to reduce the coarse Ti-Nb-Hf/Zr-(Cr) wire material to a finished wire diameter D 2 of up to 10 mm, and prepare the material for a final shape-set anneal.
  • cold work may be as little as 50%>, 75%, or 90%> and as much as 99% 99.9%, or may be any value within any range defined by any of the foregoing values.
  • the final wire diameter may be any desired diameter as required or desired for a particular application, and in certain exemplary embodiments may be as small as .05 mm, .1 mm or .5 mm and as large as 2 mm, 5 mm or 10 mm, or may be any diameter within any range defined by any of the foregoing values.
  • the cold- worked wire 10 after having been drawn to the desired finished diameter D 2 , undergoes a shape setting annealing process in which it is annealed under tension sufficient to hold the wire in a substantially linear configuration, or constrained in a specific nonlinear shape to effect a final desired geometry.
  • the heating of the wire during the shape-set annealing process allows formation of a new crystallographic structure having crystals 16, as shown in Fig. 4.
  • Crystals 16 may comprise nano-scale equiaxed crystals, though creation of such equiaxed or nanogram crystal microstructure is not required to impart the shape-memory and/or superelastic qualities described herein.
  • shape set annealing occurs at a temperature between 400
  • this heat treatment step can be accomplished in less than 10 seconds, while for larger diameter wires, e.g., between 2 mm and 10 mm, this heat treatment step may take up to 10 minutes.
  • temperature and time in the shape-setting anneal are interdependent, inversely correlated variables. That is, a higher temperature results in a shorter annealing time, while a lower temperature results in a longer annealing time to achieve the same result.
  • Exemplary time/temperature combinations which produce superelastic Ti-Nb-Hf/Zr-(Cr) wires in accordance with the present disclosure, after cold working as described above, include: 500 °C (773 K) for between 10 seconds and 1 minute; 650 °C (823 K) for between 1 second and 30 seconds; and 750 °C (923 K) for between 0.1 seconds and 10 seconds.
  • any combination of parameters may be chosen for a particular product within the scope the present disclosure, provided the annealing process restores a majority of the wire to the parent phase.
  • the material is cooled in an inert atmosphere to room temperature (i.e., about 21 °C). Such cooling may occur in air or liquid.
  • the wire is held under stress.
  • the wire may be placed and held in axial tension during the annealing process, which "trains" the finished wire into a linear configuration that will again elongate when heated past the transformation temperature.
  • any desired finished shape may be chosen for a particular wire construct as required or desired for a particular design.
  • the wire may be coiled or otherwise curved or bent into a non-linear shape to place the material under stress during the shape set anneal.
  • the modulus of elasticity of the present Ti-Nb-Hf/Zr-(Cr) material is between 50
  • the present Ti-Nb-Hf/Zr-(Cr) wire material the wire also exhibits a total isothermally recoverable strain, as measure at body temperature (i.e., 37 °C or 310K) of greater than 3%. In some instances, isothermally recoverable strain is greater than greater than 4%. Wire made in accordance with the present disclosure has at least 2% isothermally recoverable strain as measured at body temperature.
  • Testing for recoverable strain can be performed as a uniaxial tensile test at a particular temperature.
  • samples of wire made in accordance with the present disclosure were tested at a temperature T equal to 37 °C ⁇ 5 °C (310K ⁇ 5K) for the samples shown by solid and dashed lines, while a temperature of 150 °C ⁇ 5 °C (423 ⁇ 5K) was used for a sample shown in dotted lines.
  • the above-described process can be used to produce wire materials with an austenitic finish temperature A F less than 37 °C, as demonstrated in Fig. 7C, which advantageously ensures that phase transformation and, therefore, shape-memory behavior, will occur between room temperature (i.e., about 21 °C) and body temperature (i.e., about 37 °C).
  • This phase transformation can be used to effect work inside a patient's body with an implanted wire structure, such as a stent which expands as it is warmed to body temperature after initial implantation at an arterial site.
  • the present Ti-Nb-Hf/Zr-(Cr) also demonstrates high fatigue life characteristics.
  • Flex fatigue capability denoted by the alternating strain level that the wire is capable of withstanding at 10 million cycles, has been shown to be about 0.8 % strain, which is
  • Fig. 7B illustrates results of rotary beam fatigue testing of the Ti-Nb-Hf/Zr-(Cr) material made in accordance with the present disclosure, as tested at room temperature.
  • the present material is able to withstand larger nominal alternating strain percentages as compared to baseline NiTi and 316L stainless steel control materials where total cycles are in excess of 10 4 and 10 5 cycles.
  • the present Ti-Nb-Hf/Zr-(Cr) material has been shown to outperform 316L stainless steel and performed similarly to the NiTi material at about 4xl0 6 cycles.
  • the present material was found to survive greater than 10 4 cycles at strain amplitudes of about 1.2% and 1.4%, greater than 2xl0 5 cycles at strain amplitude of 1.0%, and greater than 4xl0 6 cycles at a strain amplitude of 0.8%.
  • the 1.4 mm annealed material was again cold-drawn using the techniques described above to a final diameter of 0.125 mm, thereby imparting a total cold work of greater than 99% reduction of area to the fine wire section and conditioning the material for the thermal shape-setting process.
  • the shape-setting process was accomplished by applying an axial tension and heating to 650 °C, holding for 3 seconds, and cooling in an inert atmosphere to room temperature of about 21 °C.
  • the superelastic tensile properties of this wire were verified by tensile testing using an Instron load frame. Briefly, the wire was positioned in a 125 mm gage length and clamped at the ends using pneumatic grips. Tests were conducted by displacing the wire axially at a strain rate of 0.001 /s to 1% strain and then returning to zero load. Upon reaching zero load the test was repeated to 2% strain, then to 3% strain and so on. Tests were conducted where the temperature of the test chamber and specimen were held at 37 °C and 150 °C.
  • Fig. 5 illustrates a resulting stress-strain curve for the wire tested at the 37 °C temperature.
  • the material underwent a forward stress-induced transformation from the parent high-temperature (austenite) phase to the daughter low-temperature (martensite) phase, however, upon load removal the material did not spontaneously recover the original shape.
  • Fig. 6 illustrates a resulting stress-strain curve for the wire tested at the 150 °C temperature, juxtaposed against testing conducted on a straight annealed superelastic NiTi wire at a 37 °C temperature. As illustrated, the material exhibited both forward and reverse transformation upon loading and unloading respectively. A modulus of elasticity of less than 60 GPa and axial recoverable strain of greater than 3% were observed with stress hysteresis resembling a reversible stress-induced martensitic transformation at the test temperature of 150 °C.
  • adjustments to initial alloy chemistry allow control over the transformation temperature to effect superelastic behavior over a temperature range of about -50 °C to a maximum of about 300 °C, particularly including body temperature applications. Total maximum isothermally recoverable strain was measured at about 4% true strain.
  • Fig. 7A fatigue testing of the material described above illustrates high fatigue strength as compared to control material including NiTi having an austenitic finish temperature of 15 °C and 316L stainless steel cold-drawn to impart cold work of 90%.
  • the fatigue test data of Fig. 7 was gathered in ambient air at 300 ⁇ 5K at a test rate of 60 Hz using rotary beam, fully reversed, wire fatigue testing equipment as described in U.S. Patent
  • Fig. 7B illustrates further results of the rotary beam fatigue testing of the present material at room temperature.
  • the present Ti-Nb-Hf material is able to withstand larger nominal alternating strain percentages as compared to the above-described NiTi and 316L control materials where total cycles are in excess of 10 4 and 10 5 cycles.
  • the present material outperformed 316 stainless steel and performed similarly to the NiTi material at about 4xl0 6 cycles. More particularly, the present material was found to survive greater than 10 4 cycles at strain amplitudes of about 1.2% and 1.4%, greater than 2xl0 5 cycles at strain amplitude of 1.0%, and greater than 4xl0 6 cycles at a strain amplitude of 0.8%.
  • a Ti - 25 wt.% Nb - 21 wt% Hf - 0.5 wt% Cr alloy was produced. Wires having an outer diameter of 127 ⁇ were made by drawing and annealing in accordance with the disclosure above. Samples of wires were cold worked at varying levels prior to a final anneal at 650 °C for a duration of 2 seconds.
  • Fig. 7C illustrates a resulting stress-strain curve for two wires tested at body temperature (i.e., about 37 °C), shown in solid and dashed lines respectively. These stress-strain curves are juxtaposed against a stress-strain curve for a Ti-Hf-Nb alloy wire made in accordance with Example 3, shown in a dotted line, tested at 150 °C.
  • the present wires demonstrated superelastic strain characteristics at body temperature, in which superelastic behavior was observed for wires whose strain levels exceeded 4% and were recovered with residual strain of less than 1%. Thus, superelasticity of greater than 3% was observed in the present Example.
  • Fig. 7D shows another stress-strain curve for the wire of Ti-Hf-Nb-Cr wire shown in dashed lines in Fig. 7C, in which the wire was tested at body temperature (37 °C, shown in dotted lines), 70 °C (shown in dashed lines) and 100 °C (shown in solid lines).
  • each test demonstrated superelastic behavior in which residual strain subtracted from peak strain upon initial loading is greater than 2%. Specifically, this value was 2.2% for the 100 °C test sample, 2.8% for the 70 °C test sample, and 3.2% for the 37 °C test sample.
  • a second stress-strain curve resulting from a second loading of each wire illustrating that the second loading of each wire results in a stress plateau commensurate with the initial loading.
  • Wires made in accordance with the present process may be used in applications including, but not limited to stents, guidewires (e.g., to guide catheters through blood vessels), aneurysm occlusion devices, heart wall closure devices, orthodontic wires and apparatuses, surgical anchoring devices, etc.
  • the Ti-Hf-Nb alloy material advantageously serves as a radiopaque, superelastic material which may be produced at reduced cost and with enhanced fatigue damage resistance.
  • the present Ti-Hf-Nb alloy systems have application potential wherever high-strength, low-modulus beta titanium alloys would be appropriate, including in applications such as guide wires, pacing wires, or stents where the low modulus, corrosion resistance, and high strain fatigue capability of the present alloy systems are leveraged in the absence of shape memory behavior.
  • a percutaneous transluminal coronary angioplasty (PTCA) guide wire 300 is shown which comprises a metallic elongate wire 302 manufactured in accordance with the present process with tapered end 302'. Wire 302 is received within a coil wire 304, which in turn is received within a housing 306.
  • PTCA percutaneous transluminal coronary angioplasty
  • PTCA guide wires are used to access distal locations within the human body to treat vessel lesion in including, for example, atherosclerosis, or in order to facilitate implantation of a defibrillation electrode. In order to reach these locations, guide wires must flex sufficiently to navigate the anatomy en route to the target lesion or organ.
  • the elastic properties of the guide wire may be important in guide wire design because the wire should conform to the tortuous vessel anatomy as it is used to access various targeted locations for treatment within the body, such as the right ventricle of the heart as shown in Fig. 9.
  • the guide wire should successfully navigate the anatomy without suffering a material failure.
  • the present process provides a wire that possesses a high degree of flexibility due to a relatively high yield to ultimate strength ratio which is greater than 0.85, thereby imparting a relatively high yield strain to the guide wire.
  • a physician will manually shape the tip section of a guide wire in order to facilitate navigation of specific vessel anatomy.
  • a material must possess the ability to both accept plastic deformation, in order to take a specific shape, and maintain good resilience to successfully move through the anatomy.
  • the present process provides a wire that is radiopaque, so that the location and orientation of the guide wire within a patient's body is verifiable via medical imaging methods such as X-ray.
  • Wire 302 prepared in accordance with the present process provides a combination of superelastic behavior with radiopacity, thereby increasing the ability of wire 302 to withstand both pre-procedural, physician-planned plastic deformation and subsequent procedural elastic deformation en route to the target lesion, while also facilitating in vivo location of the wire via medical imaging.
  • FIG. 9 a first cardiac pacing lead wire 310 and second cardiac pacing lead wire 312 made in accordance with the present process are shown.
  • Wires 310, 312 are utilized either singularly or in plurality in the form of a conductive braid, strand or microcable which is used to deliver therapeutic electrical signals to the heart.
  • the cardiac pacing lead wires 310, 312 may comprise a combination of coiled wires 314 and/or microcable elements 316 which are overmolded and/or separated by an electrically insulating polymer sleeve 318 such as medical-grade polyurethane or silicone rubber. Sleeves 318 and wires 314, 316 are received within a housing 320.
  • the lead is implanted within the right atrium and/or ventricle
  • V of the heart H in order to deliver an electrical control signal thereby stimulating or otherwise providing pacing, defibrillation or cardiac resynchronization therapy in order to treat bradycardia, tachycardia, or other arrhythmias of the heart.
  • lead wires 310, 312, or similar systems utilizing wires made in accordance with the invention may also be implanted with electrical connection to the outside of the heart the left atrium and the left ventricle.
  • Required material characteristics are generally similar to those described earlier.
  • pacing lead wires 310, 312 be substantially resistant to cyclic mechanical fatigue damage which is generally associated with the spatial displacement of the lead system with each beat of the heart at an average rate of up to 2 Hz.
  • cardiac lead wires 310, 312 may undergo some plastic deformation due to loads imparted to the system during implantation.
  • lead wires 310, 312 will benefit from being capable of withstanding implant- load-related deformation and post-implant geometry-controlled cyclic deformation. Enhancement of lead wires 310, 312 may be realized by selection of metallic wire materials possessing high levels of fatigue endurance and ductility.
  • wires 310, 312 provide a high level of fatigue endurance strain in geometry-controlled loading and ductility and may therefore provide enhanced long term device performance when placed into any of a variety of cardiac lead designs. Also
  • wires 310, 312 are free of nickel, which may prevent adverse reaction in patients having a sensitivity to nickel (as also described below with regard to wire-based stents).
  • Wire made in accordance with the present process may also be used for leads for gastric, neurological, or other biological electrical stimulation.
  • a tissue scaffold or vessel stent device 370 is shown which is made from one or more wires 372 made in accordance with the present process, which are braided, knitted, or otherwise formed together to produce the generally cylindrical cross- sectional shape of device 370.
  • tissue scaffold or vessel stent device 370' is shown which is made from one or more wires 372' made in accordance with the present process, which are knitted together to form the generally cylindrical cross-sectional shape of device 370'.
  • stents Upon release from the delivery catheter, stents move to some degree, dependent on the relative vessel and device compliance, with the artery due to fluctuations in blood pressure, arterial vessel smooth muscle contraction and dilation, and due to general anatomical movement. Such mechanical displacement results in cyclic straining of wires 372, 372' comprising the structure of stent 370, 370' structure.
  • Non bioerodable tissue scaffolds or stents are generally implanted permanently, and therefore should be able to withstand millions of mechanical load cycles without losing structural integrity due to mechanical fatigue.
  • Stents 370, 370' which are constructed from wires 372, 372' made in accordance with the present process, possess a high degree of resistance to fatigue damage and thus offer optimized performance as compared to conventional stents made with wires having lower fatigue strength.
  • wire made in accordance with the present disclosure is also free of nickel, while preserving the shape-memory qualities and resistance to fatigue damage of wires containing nickel as a major constituent (e.g., NiTi).
  • nickel as a major constituent
  • wire made of the present Ti-Hf-Nb alloy may be a viable alternative with no loss in material performance.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Thermal Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

L'invention concerne des fils à mémoire de forme en alliage Ti-Nb-Hf/Zr-(Cr) qui conviennent à une utilisation dans des dispositifs et des actionneurs médicaux, et des procédés pour fabriquer ces fils. Le présent alliage Ti-Nb-Hf/Zr-(Cr) à mémoire de forme est un matériau de fil superplastique particulièrement adapté à des applications in vivo Par exemple, le présent alliage Ti-Nb-Hf/Zr-(Cr) est radio-opaque, ce qui permet l'utilisation chirurgicale d'un fil en alliage à mémoire de forme monolithique tout en conservant la capacité à suivre la localisation in vivo du fil par des systèmes d'imagerie basés sur les rayons X ou un autre rayonnement. En outre, le présent alliage Ti-Nb-Hf/Zr-(Cr) peut être fabriqué pour présenter des propriétés de matériau d'alliage à mémoire de forme sans utiliser de nickel comme constituant de l'alliage, et convient ainsi aux patients sensibles au nickel. Le présent alliage Ti-Nb-Hf/Zr-(Cr) peut également être traité pour présenter une température de transformation martensite/austénite proche de la température corporelle, c'est-à-dire, 37 °C, de telle sorte que les effets de mémoire de forme puissent être utilisés pour accomplir une tâche in vivo.
PCT/US2014/036961 2013-05-06 2014-05-06 Fil a mémoire de forme en alliage titane-niobium-hafnium Ceased WO2014182691A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/889,101 US10315012B2 (en) 2013-05-06 2014-05-06 Titanium-niobium-hafnium alloy shape memory wire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361819798P 2013-05-06 2013-05-06
US61/819,798 2013-05-06

Publications (2)

Publication Number Publication Date
WO2014182691A2 true WO2014182691A2 (fr) 2014-11-13
WO2014182691A3 WO2014182691A3 (fr) 2015-01-22

Family

ID=51867853

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/036961 Ceased WO2014182691A2 (fr) 2013-05-06 2014-05-06 Fil a mémoire de forme en alliage titane-niobium-hafnium

Country Status (2)

Country Link
US (1) US10315012B2 (fr)
WO (1) WO2014182691A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018089028A1 (fr) 2016-11-14 2018-05-17 Fort Wayne Metals Research Products Corp Alliages de bêta-titane sans nickel à mémoire de forme et propriétés super-élastiques
WO2018162919A1 (fr) * 2017-03-10 2018-09-13 Ilika Technologies Limited Alliages de titane
CN109652639A (zh) * 2018-12-29 2019-04-19 佛山市诚德新材料有限公司 一种不锈钢带的退火炉
CN115161533A (zh) * 2022-06-10 2022-10-11 北京理工大学 一种ZrCu基高熵形状记忆合金及其制备方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106929779B (zh) * 2017-03-10 2018-10-12 佳禾智能科技股份有限公司 一种记忆金属丝定型治具及其加工记忆金属丝的方法
RU2656626C1 (ru) * 2017-05-15 2018-06-06 Федеральное государственное бюджетное учреждение науки Институт металлургии и материаловедения им. А.А. Байкова Российской академии наук (ИМЕТ РАН) Способ получения проволоки из сплава титан-ниобий-тантал-цирконий с эффектом памяти формы
US10939990B2 (en) * 2017-11-28 2021-03-09 Medtronic Vascular, Inc. Graft material having selectively advanced permeability structure and method
CN108624747B (zh) * 2018-06-28 2024-03-26 上海理工大学 一种主动脉支架环定形模具
CA3126019A1 (fr) 2019-01-18 2020-07-23 W. L. Gore & Associates, Inc. Dispositifs medicaux bioabsorbables
US11697869B2 (en) * 2020-01-22 2023-07-11 Heraeus Deutschland GmbH & Co. KG Method for manufacturing a biocompatible wire
US11420022B2 (en) * 2020-03-06 2022-08-23 Stryker Corporation Actuating elements for bending medical devices
EP3885465A1 (fr) * 2020-03-27 2021-09-29 Heraeus Materials Singapore Pte. Ltd. Procédé d'augmentation de la rectitude d'un fil mince

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165292A (en) * 1990-12-18 2000-12-26 Advanced Cardiovascular Systems, Inc. Superelastic guiding member
US7128757B2 (en) * 2000-12-27 2006-10-31 Advanced Cardiovascular, Inc. Radiopaque and MRI compatible nitinol alloys for medical devices
US7722805B2 (en) * 2003-12-25 2010-05-25 Institute Of Metal Research Chinese Academy Of Sciences Titanium alloy with extra-low modulus and superelasticity and its producing method and processing thereof
EP2121055B1 (fr) * 2007-02-13 2014-04-02 Abbott Cardiovascular Systems Inc. Alliages radio-opaques compatibles avec l'irm à utiliser dans les dispositifs médicaux
US8142490B2 (en) 2007-10-24 2012-03-27 Cordis Corporation Stent segments axially connected by thin film
US8500657B2 (en) * 2010-08-23 2013-08-06 Abbott Cardiovascular Systems, Inc. Twisted ribbon wire guidewire coil

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018089028A1 (fr) 2016-11-14 2018-05-17 Fort Wayne Metals Research Products Corp Alliages de bêta-titane sans nickel à mémoire de forme et propriétés super-élastiques
EP3538681A4 (fr) * 2016-11-14 2020-03-18 Fort Wayne Metals Research Products Corporation Alliages de bêta-titane sans nickel à mémoire de forme et propriétés super-élastiques
US11111571B2 (en) 2016-11-14 2021-09-07 Fort Wayne Metals Research Products Ni-free beta Ti alloys with shape memory and super-elastic properties
WO2018162919A1 (fr) * 2017-03-10 2018-09-13 Ilika Technologies Limited Alliages de titane
CN109652639A (zh) * 2018-12-29 2019-04-19 佛山市诚德新材料有限公司 一种不锈钢带的退火炉
CN109652639B (zh) * 2018-12-29 2024-02-09 佛山市诚德新材料有限公司 一种不锈钢带的退火炉
CN115161533A (zh) * 2022-06-10 2022-10-11 北京理工大学 一种ZrCu基高熵形状记忆合金及其制备方法

Also Published As

Publication number Publication date
US20160151610A1 (en) 2016-06-02
US10315012B2 (en) 2019-06-11
WO2014182691A3 (fr) 2015-01-22

Similar Documents

Publication Publication Date Title
US10315012B2 (en) Titanium-niobium-hafnium alloy shape memory wire
US11001910B2 (en) Fatigue strength of shape memory alloy tubing and medical devices made therefrom
JP5927405B2 (ja) 耐疲労損傷性ワイヤおよびその製造方法
EP3056166B1 (fr) Articles en alliage à mémoire de forme possédant une résistance à la fatigue améliorée
EP3975942B1 (fr) Alliages résorbables à base de magnésium
US20160138148A1 (en) Biodegradable wire for medical devices
JP2005508229A (ja) 加工硬化擬弾性ガイドワイヤ
EP3538681B1 (fr) Alliages de bêta-titane sans nickel à mémoire de forme et propriétés super-élastiques
US20250381323A1 (en) Composite wire with coating
EP4569523A1 (fr) Fil composite avec revêtement
BR112019009699B1 (pt) Liga e material de beta-titânio com traços de níquel, e, método para produzir uma liga de beta-titânio com traços de níquel

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14794001

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 14794001

Country of ref document: EP

Kind code of ref document: A2